Not Medicare Enrolled

Christina Zazay, APRN, PMHNP-BC

Psychiatric/Mental Health Nurse Practitioner · Plano, TX
7707 SAN JACINTO PL STE 300, Plano, TX 75024
2142271300
Registered in NPPES since 2020
NPI: 1588298996 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Zazay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Zazay? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Zazay

Christina Zazay is a psychiatric/mental health nurse practitioner in Plano, TX, with 6 years of NPI registration.

Between the years covered by Open Payments, Zazay received a total of $12,868 from 33 pharmaceutical and/or device companies across 636 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Zazay is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $12,868 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,868
Total received (2021-2024)
Avg $3,217/year across 4 years
Top 1% in TX for psychiatric/mental health nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
636
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,508
2023
$4,094
2022
$2,600
2021
$2,666

Payments by company (2024)

IRONSHORE PHARMACEUTICALS INC.
$683
Axsome Therapeutics, Inc.
$442
Janssen Pharmaceuticals, Inc
$329
ABBVIE INC.
$328
Tris Pharma Inc
$296
Otsuka America Pharmaceutical, Inc.
$281
Supernus Pharmaceuticals, Inc.
$251
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$221
Alkermes, Inc.
$213
Neurocrine Biosciences, Inc.
$161
Corium, LLC
$132
Noven Therapeutics, LLC
$65
Lundbeck LLC
$42
Teva Pharmaceuticals USA, Inc.
$30
Almatica Pharma LLC
$18
Neos Therapeutics, LP
$14
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2021-2024) ›
Alkermes, Inc.
$1,688
ABBVIE INC.
$1,114
Otsuka America Pharmaceutical, Inc.
$1,102
Janssen Pharmaceuticals, Inc
$1,007
Axsome Therapeutics, Inc.
$874
Ironshore Pharmaceuticals Inc.
$690
IRONSHORE PHARMACEUTICALS INC.
$683
Tris Pharma Inc
$620
Neurocrine Biosciences, Inc.
$606
Sunovion Pharmaceuticals Inc.
$509
Supernus Pharmaceuticals, Inc.
$486
Corium, LLC
$478
Teva Pharmaceuticals USA, Inc.
$426
ITI, Inc.
$408
AbbVie Inc.
$281
Lundbeck LLC
$280
Avanir Pharmaceuticals, Inc.
$264
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$221
Corium, Inc.
$213
Bausch Health US, LLC
$189
Takeda Pharmaceuticals U.S.A., Inc.
$186
Eisai Inc.
$149
Noven Therapeutics, LLC
$118
IDORSIA PHARMACEUTICALS US INC
$69
Merck Sharp & Dohme LLC
$33
Neos Therapeutics, LP
$33
Almatica Pharma LLC
$33
Adlon Therapeutics L.P.
$26
JAZZ PHARMACEUTICALS INC.
$24
Arbor Pharmaceuticals, Inc.
$16
Indivior Inc.
$14
Merck Sharp & Dohme Corporation
$14
Janssen Biotech, Inc.
$12
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · GRALISE · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · NUEDEXTA · Nuedexta · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillivant · REXULTI · SPRAVATO · SUNOSI · Secuado · Sunosi · TRINTELLIX · UZEDY · VRAYLAR · Xelstrym
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatric/mental health nurse practitioner in Plano?
Compare psychiatric/mental health nurse practitioners in the Plano area by procedure volume, costs, and industry payment transparency.
Browse psychiatric/mental health nurse practitioners nearby

Geographic Context

Psychiatric/mental health nurse practitioners in nearby ZIP areas
632
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Zazay is a psychiatric/mental health nurse practitioner.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Zazay receive payments from pharmaceutical companies?
Yes. Zazay received a total of $12,868 from 33 companies across 636 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Zazay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →